Giuffre Randall Michael 4
4 · DiaMedica Therapeutics Inc. · Filed Jan 2, 2024
Insider Transaction Report
Form 4
Giuffre Randall Michael
Director
Transactions
- Award
Voting Common Shares, no par value per share
2024-01-02$2.80/sh+19,196$53,749→ 364,551 total
Holdings
- 25,573(indirect: See footnote)
Voting Common Shares, no par value per share
- 21,070(indirect: By Spouse)
Voting Common Shares, no par value per share
Footnotes (3)
- [F1]These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $53,750.
- [F2]Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 84,155 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 111,360 voting common shares held by Michael Giuffre individually.
- [F3]These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.